Cardoner N

https://ror.org/059n1d175Institut d'Investigació Biomèdica Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

5 papers · ORCID

ArticleKetamine

Trajectory of response to esketamine nasal spray for treatment resistant depression: Findings from ESCAPE-TRD.

Young AH, Bartova L, Cardoner N +9

Europe PMC2026
Article5-MeO-DMT

GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.

Cubala WJ, Bajbouj M, Bauer M +30

Europe PMC2026
ArticleKetamine

Outcomes with esketamine nasal spray in patients with or without earlier partial or full response: post hoc analyses of ESCAPE TRD

Young A, Godinov Y, Rive B +8

Europe PMC2025
ArticleKetamine

Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial - ERRATUM.

Young AH, Llorca PM, Fagiolini A +9

Europe PMC2025
ArticleKetamine

Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial.

Young AH, Llorca PM, Fagiolini A +9

Europe PMC2025